Atlas Trials

Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT00183872 · COMPLETED

Trial details

NCT number
NCT00183872
Sponsor
University of Southern California
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerEsophageal Neoplasms
Start date
2005-04-14
Primary completion
2014-10-20
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.